TITLE

OTHER NEWS TO NOTE

PUB. DATE
January 2008
SOURCE
BioWorld Today;1/17/2008, Vol. 19 Issue 12, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs on the pharmaceutical industry. A Phase I Small Business Innovation Research grant has been awarded by the National Cancer Institute to Carigent Therapeutics Inc. Cephalon Inc. is expecting to close its manufacturing facility and transition activities to its Salt Lake City facility within two or three years. Nycomed's inhaled corticosteroid, Alvesco, ciclesonide, has been approved by the U.S. Food and Drug Administration.
ACCESSION #
28524147

 

Related Articles

  • NCI to Award $10M in Small Business Grants.  // BioWorld Today;2/22/2011, Vol. 22 Issue 35, p4 

    The article reports that a total of 10 million dollars in grants is to be awarded by the U.S. National Cancer Institute for 2011, to help businesses that need additional funding to support next stage development of cancer therapeutics, imaging technologies, interventional devices, diagnostics...

  • National Cancer Institute Awards Labcyte $1 Million for Novel High-Throughput Cancer Biomarker Detection.  // Spectroscopy;Jan2014, Vol. 29 Issue 1, p12 

    The article reports that the U.S. National Cancer Institute has given the acoustic dispensing company Labcyte Inc., a $1 million research grants, for the development of a medical device for detection of cancer-related proteins in human samples for diagnosis of breast cancer in patients in 2014.

  • The NCI Recovery Act grants.  // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p46 

    A blog from Noelle LoConte about the National Cancer Institute Recovery Act grants is discussed.

  • Biotechs Led in New Drugs for '08.  // BioWorld Today;1/5/2009, Vol. 20 Issue 1, p7 

    The article reveals that the biotechnology industry has surpassed big pharmaceutical firms in achieving U.S. Food and Drug Administration (FDA) approvals of new molecular entities (NME) and new biologics in 2008. 80 new drug applications (NDA) and biologic license applications (BLA) for...

  • Critical illness-related corticosteroid insufficiency in cancer patients. Bruno, Jeffrey; Hernandez, Mike; Ghosh, Shubhra; Pravinkumar, S. // Supportive Care in Cancer;Jun2012, Vol. 20 Issue 6, p1159 

    Purpose: Critically ill cancer patients with sepsis represent a high-risk sub-group for the development of critical illness-related corticosteroid insufficiency (CIRCI); however, the incidence of CIRCI in this population is unknown. The purpose of this study was to determine the incidence of...

  • (HEALTHCARE) $2.5M Available for Cancer Research Training.  // Community Health Funding Week;10/16/2009, p4 

    The article informs that applications have been invited by the National Cancer Institute of the National Institutes of Health (NIH) for the development of Cancer Nanotechnology Training Centers. These centres should be designed to establish innovative research education programs.

  • Berkeley Cancer Genome Center to Study Tumor Genomics.  // Ascribe Newswire: Medicine;10/16/2006, p3 

    The article reports that Berkeley Cancer Genome Center, a cancer research institute, will receive research grants from the National Cancer Institute and the National Human Genome Research Institute. Paul Spellman, a computational biologist and codirector of the center, said that the institute...

  • The National Cancer Institute's Cancer Education (R25E) Grants Program: An Update. Blehar, Mary C.; Strete, Carolyn // Journal of Cancer Education;Summer2005, Vol. 20 Issue 2, p67 

    Provides information on the Cancer Education Grants Program of the U.S. National Cancer Institute. Background on the program; Features of the program; Eligibility for application; Evaluation plan of all grants.

  • NCI launches network to study genetic predisposition to cancer. SWEENEY, ROSEMARIE; ROSE, VERNA L. // American Family Physician;12/1/1998, Vol. 58 Issue 9, p1948 

    Reports that the National Cancer Institute (NCI) has awarded cooperative agreements for a Cancer Genetics Network, a research initiative to create a national network of centers specializing in the study of inherited predisposition to cancer. List of institutions that have received the awards.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics